Biography

Dr. Amani Alghalayini completed her PhD in 2020 at the Cell Biology and NanoBiotechnology lab at UTS. Her research focused on innovative applications of lipid-membrane-coated electrodes, including electrode surfaces for neuronal cell adhesion, nano-biosensors for direct cell detection, and sensors for monitoring membrane disruption caused by laser-irradiated gold nanoparticles. She pioneered a novel real-time membrane biosensor, contributing valuable insights into the use of gold nanoparticles for localized heating in biomedical applications.

With expertise in cell biology, molecular biology, biophysics, biotechnology, biochemistry, and sensor development, Dr. Alghalayini has made significant contributions to translational research. As a postdoctoral researcher at UTS, she worked on an ion channel switch sensor project with Surgical Diagnostics, focusing on in vitro diagnostics and drug screening. She also played a key role in developing a rapid point-of-care testing cartridge for SARS-CoV-2 in collaboration with Alcolizer Technology, including establishing antibody screening cell lines, sensor development, and clinical trials. Her work has been featured in Australian media, including IMCRC reports and 7news.

Dr. Alghalayini is currently focusing on identifying new therapies for ovarian cancer using a precision medicine approach to overcome chemo-resistance and improve patient outcomes.

She has interest in science communication and translation. Outside work, she is a wife and the mother of four children.

Amani identifies as culturally and linguistically diverse.

Featured